JPWO2022190967A1 - - Google Patents

Info

Publication number
JPWO2022190967A1
JPWO2022190967A1 JP2023505328A JP2023505328A JPWO2022190967A1 JP WO2022190967 A1 JPWO2022190967 A1 JP WO2022190967A1 JP 2023505328 A JP2023505328 A JP 2023505328A JP 2023505328 A JP2023505328 A JP 2023505328A JP WO2022190967 A1 JPWO2022190967 A1 JP WO2022190967A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023505328A
Other languages
Japanese (ja)
Other versions
JP7848179B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022190967A1 publication Critical patent/JPWO2022190967A1/ja
Application granted granted Critical
Publication of JP7848179B2 publication Critical patent/JP7848179B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023505328A 2021-03-09 2022-03-01 リン脂質 Active JP7848179B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021037573 2021-03-09
JP2021037573 2021-03-09
PCT/JP2022/008670 WO2022190967A1 (ja) 2021-03-09 2022-03-01 リン脂質

Publications (2)

Publication Number Publication Date
JPWO2022190967A1 true JPWO2022190967A1 (https=) 2022-09-15
JP7848179B2 JP7848179B2 (ja) 2026-04-20

Family

ID=83227160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505328A Active JP7848179B2 (ja) 2021-03-09 2022-03-01 リン脂質

Country Status (5)

Country Link
US (1) US20230295199A1 (https=)
EP (1) EP4306531A4 (https=)
JP (1) JP7848179B2 (https=)
CN (1) CN116234538A (https=)
WO (1) WO2022190967A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120712274A (zh) * 2023-02-14 2025-09-26 静冈县公立大学法人 pH响应性磷脂

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4826936A (https=) * 1971-08-14 1973-04-09
JPS5484530A (en) * 1977-11-24 1979-07-05 Max Planck Gesellschaft Novel compounds of phosphorus lipid analogues* their manufacture and manufacture of plant mongrels
JPS6041494A (ja) * 1983-04-11 1985-03-05 Meito Sangyo Kk 酵素法リン脂質一級アルコ−ル誘導体の製法
JP2005247750A (ja) * 2004-03-04 2005-09-15 Takemoto Oil & Fat Co Ltd リン脂質誘導体及び遺伝子導入キャリア
WO2018190017A1 (ja) * 2017-04-11 2018-10-18 日本精化株式会社 核酸導入用脂質誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10207177A1 (de) * 2002-02-19 2003-09-04 Novosom Ag Fakultativ kationische Lipide
WO2019005830A1 (en) * 2017-06-26 2019-01-03 Fordoz Pharma Corp. NANOSOME FORMULATIONS OF APREPITANT AND METHODS AND APPLICATIONS THEREOF

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4826936A (https=) * 1971-08-14 1973-04-09
JPS5484530A (en) * 1977-11-24 1979-07-05 Max Planck Gesellschaft Novel compounds of phosphorus lipid analogues* their manufacture and manufacture of plant mongrels
JPS6041494A (ja) * 1983-04-11 1985-03-05 Meito Sangyo Kk 酵素法リン脂質一級アルコ−ル誘導体の製法
JP2005247750A (ja) * 2004-03-04 2005-09-15 Takemoto Oil & Fat Co Ltd リン脂質誘導体及び遺伝子導入キャリア
WO2018190017A1 (ja) * 2017-04-11 2018-10-18 日本精化株式会社 核酸導入用脂質誘導体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ASAI, T. ET AL.: "Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery", BIOCONJUGATE CHEMISTRY, vol. 22, no. 3, JPN6018018575, 2011, pages 429 - 435, ISSN: 0005812883 *
NAGATA, T. ET AL.: "Fusion of plant protoplasts induced by a positively charged synthetic phospholipid", ZEITSCHRIFT FUER NATURFORSCHUNG, C: JOURNAL OF BIOSCIENCES, vol. Vol. 34C, No. 5-6, JPN6018018573, 1979, pages 460 - 462, ISSN: 0005812884 *
冨田 康治 他: "ピペラジン骨格を有する新規機能性脂質の開発", 第36回日本DDS学会学術集会プログラム予稿集, JPN6022019765, 10 August 2020 (2020-08-10), pages 197, ISSN: 0005738063 *

Also Published As

Publication number Publication date
US20230295199A1 (en) 2023-09-21
EP4306531A1 (en) 2024-01-17
WO2022190967A1 (ja) 2022-09-15
JP7848179B2 (ja) 2026-04-20
CN116234538A (zh) 2023-06-06
EP4306531A4 (en) 2025-02-19

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
JPWO2022190967A1 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260108

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260408

R150 Certificate of patent or registration of utility model

Ref document number: 7848179

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150